Historical record - last NADAC effective date: 1/23/2019
Product Information
ALLI 60 MG CAPSULE is a brand product labeled by Haleon US Holdings LLC, priced at $0.4820 per EA under NDC 00135046102. Its NADAC has been published 301 times since Nov 28, 2013.
FDA first approved this application on Feb 7, 2007.
Strength
60 mg/1
Manufacturer
Haleon US Holdings LLCNDC
00135046102
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Effective Date
1/23/2019
Active Ingredients
ORLISTATApproval Type
New Drug (NDA)
FDA Application
NDA021887FDA Approved
2/7/2007
On Market Since
2/7/2007
Pharmacological Classes
Price Statistics
The NADAC for ALLI 60 MG CAPSULE has been published 301 times since Nov 28, 2013, and over the history we have for it it has declined 3.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4820 per EA |
|---|---|
| All-time high | $0.4971 (Jan 15, 2014) |
| All-time low | $0.4284 (Jun 22, 2016) |
| Median price | $0.4606 |
| Average price | $0.4559 |
| Largest weekly change | -12.5% (Jan 22, 2014) |
| Weeks tracked | 301 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-3.0%
Last surveyed Aug 28, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Haleon US Holdings LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
orlistat market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Intestinal Lipase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ALLI 60 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ALLI 60 MG CAPSULE, manufactured by Haleon US Holdings LLC, is $0.4820 per EA (NDC 00135046102), effective Aug 28, 2019.
How has the price of ALLI 60 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ALLI 60 MG CAPSULE has declined 3.0%. It has been tracked across 301 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ALLI 60 MG CAPSULE?
Since Nov 28, 2013, the NADAC for ALLI 60 MG CAPSULE has ranged from a low of $0.4284 (Jun 22, 2016) to a high of $0.4971 (Jan 15, 2014), with a median of $0.4606 per EA.
Are there cheaper alternatives to ALLI 60 MG CAPSULE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ALLI 60 MG CAPSULE, is $0.4536 per EA — about 6% below ALLI 60 MG CAPSULE.
Who manufactures ALLI 60 MG CAPSULE?
ALLI 60 MG CAPSULE (NDC 00135046102) is labeled by Haleon US Holdings LLC, and CMS classifies it as a brand product.